In addition, microarray analysis showed that key nuclear receptor family genes such as NR4A1 (Nur77) and NR4A2 (Nurr1), which are important for the nuclear receptor-dependent apoptosis in the peripheral blood of the pre-disease state in MS patients, were suppressed [109]. This evidence concerns the gene NR4A1 and myeloid sarcoma.